Angela Tincani
Brescia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 330 publications
Correction: Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohorts.
Journal: Frontiers in immunology
Published: May 12, 2026
ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).
Journal: The Lancet. Rheumatology
Published: February 17, 2026
Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohorts.
Journal: Frontiers in immunology
Published: February 11, 2026
Monoclonal Antibodies in Pregnancy of Patients with Systemic Lupus Erythematosus: Friend or Foe? A Case Report of a Patient with Multiple Pregnancies.
Journal: Antibodies (Basel, Switzerland)
Published: February 10, 2026
Criterion validity of the EULAR Antiphospholipid Syndrome Disease Activity Score (EAPSDAS).
Journal: Annals of the rheumatic diseases
Published: January 09, 2026
The landscape of serum autoantibodies in lupus nephritis.
Journal: Autoimmunity reviews
Published: January 04, 2026
Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: November 11, 2025
Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long-Term Follow-Up.
Journal: Arthritis care & research
Published: September 25, 2025
Primary antiphospholipid syndrome and the kidney: biopsy-proven insights from two referral Italian centres.
Journal: Rheumatology (Oxford, England)
Published: July 29, 2025
Unmet needs and challenges in the diagnosis and management of antiphospholipid syndrome: a qualitative stakeholder study within the ReCONNET framework.
Journal: Lupus science & medicine
Published: June 11, 2025
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries.
Journal: The Lancet. Rheumatology
Published: June 01, 2025
Development and validation of a EULAR disease activity score in antiphospholipid syndrome.
Journal: Annals of the rheumatic diseases
Published: April 23, 2025
Last Updated: 09/26/2026